Characterization of extended-spectrum beta-lactamases and antimicrobial resistance of Klebsiella pneumoniae in intra-abdominal infection isolates in Latin America, 2008-2012. Results of the Study for Monitoring Antimicrobial Resistance Trends

Diagnostic Microbiology and Infectious Disease

Volumn 82, Issue 3, 2015, Pages 209-214

  Kazmierczak, Krystyna M ^a   Lob, Sibylle H ^a   Hoban, Daryl J ^a   Hackel, Meredith A ^a   Badal, Robert E ^a   Bouchillon, Samuel K ^a  

^a International Health Management Associates   (United States)

Author keywords

Beta lactamase; Klebsiella pneumoniae; Resistance

Indexed keywords

AMIKACIN; BETA LACTAMASE AMPC; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; TREND STUDY; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HUMAN; INCIDENCE; INTRAABDOMINAL INFECTIONS; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MICROBIOLOGY; SECRETION (PROCESS);

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; DRUG RESISTANCE, BACTERIAL; HUMANS; INCIDENCE; INTRAABDOMINAL INFECTIONS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LATIN AMERICA;

EID: 84941184344     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.03.025     Document Type: Article

References (25)

1. Badal R., Hoban D., Bouchillon S., Johnson J., Hackel M., Biedenbach D., et al. Variability in susceptibility of Klebsiella pneumoniae from intra-abdominal infections in Asian countries. Abstract, International Symposium on Antimicrobial Agents and Resistance (ISAAR), Kuala Lumpur, Malaysia, 2013 2013.
2. Carvalhaes C.G., Picao R.C., Nicoletti A.G., Xavier D.E., Gales A.C. Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results. J Antimicrob Chemother 2010, 65(2):249-251. 10.1093/jac/dkp431.
3. Chen Y.H., Hsueh P.R., Badal R.E., Hawser S.P., Hoban D.J., Bouchillon S.K., et al. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect 2011, 62(4):280-291. 10.1016/j.jinf.2011.02.009.
4. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement (M100-S23) 2013, CLSI, Wayne, PA.
5. KPC-2 gene. Emerg Infect Dis 2010, 16(9):1349-1356. 10.3201/eid1609.091389.
6. Fernandez-Canigia L., Dowzicky M.J. Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010. Ann Clin Microbiol Antimicrob 2012, 11:29-37. 10.1186/1476-0711-11-29.
7. Gales A.C., Castanheira M., Jones R.N., Sader H.S. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010). Diagn Microbiol Infect Dis 2012, 73(4):354-360. 10.1016/j.diagmicrobio.2012.04.007.
8. Guzman-Blanco M., Labarca J.A., Villegas M.V., Gotuzzo E., Latin America Working Group on Bacterial Resistance Extended spectrum beta-lactamase producers among nosocomial Enterobacteriaceae in Latin America. Braz J Infect Dis 2014, 18(4):421-433. 10.1016/j.bjid.2013.10.005.
9. Hawser S.P., Bouchillon S.K., Lascols C., Hackel M., Hoban D.J., Badal R.E., et al. Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates. Antimicrob Agents Chemother 2011, 55(8):3917-3921. 10.1128/AAC.00070-11.
10. Hoban D.J., Bouchillon S.K., Hawser S.P., Badal R.E. Trends in the frequency of multiple drug-resistant Enterobacteriaceae and their susceptibility to ertapenem, imipenem, and other antimicrobial agents: data from the Study for Monitoring Antimicrobial Resistance Trends 2002 to 2007. Diagn Microbiol Infect Dis 2010, 66(1):78-86. 10.1016/j.diagmicrobio.2009.06.009.
11. Hoban D.J., Lascols C., Nicolle L.E., Badal R., Bouchillon S., Hackel M., et al. Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009-2010. Diagn Microbiol Infect Dis 2012, 74(1):62-67. 10.1016/j.diagmicrobio.2012.05.024.
12. Hoban D.J., Badal R., Bouchillon S., Hackel M., Kazmierczak K., Lascols C., et al. In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010-2011. Diagn Microbiol Infect Dis 2014, 79(3):367-372. 10.1016/j.diagmicrobio.2014.03.026.
13. Jacoby G.A., Mills D.M., Chow N. Role of beta-lactamases and porins in resistance to ertapenem and other beta-lactams in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004, 48(8):3203-3206.
14. Jones R.N., Guzman-Blanco M., Gales A.C., Gallegos B., Castro A.L., Martino M.D., et al. Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011). Braz J Infect Dis 2013, 17(6):672-681. 10.1016/j.bjid.2013.07.002.
15. Lob S., Badal R., Biedenbach D., Johnson A., Sahm D. Trends in susceptibility and multi-drug resistance in K. pneumoniae from intra-abdominal infections in Western Europe 2009-2013. Abstract EV0089, 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Copenhagen, Denmark, 2015 2015, [http://eccmid.meetingexpert.net/ECCMID_546/poster_121474/program.aspx/anchor121474].
16. Martinez-Martinez L. Extended-spectrum beta-lactamases and the permeability barrier. Clin Microbiol Infect 2008, 14(Suppl. 1):82-89.
17. Minarini L.A., Gales A.C., Palazzo I.C., Darini A.L. Prevalence of community-occurring extended spectrum beta-lactamase-producing Enterobacteriaceae in Brazil. Curr Microbiol 2007, 54(5):335-341.
18. Munoz-Price L.S., Poirel L., Bonomo R.A., Schwaber M.J., Daikos G.L., Cormican M., et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013, 13(9):785-796. 10.1016/S1473-3099(13)70190-7.
19. Pai H., Seo M.-R., Choi T.Y. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 2007, 51(1):366-368.
20. Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005, 18(4):657-686.
21. Reinert R.R., Low D.E., Rossi F., Zhang X., Wattal C., Dowzicky M.J. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 2007, 60(5):1018-1029.
22. Rice L.B., Carias L.L., Hujer A.M., Bonafede M., Hutton R., Hoyen C., et al. High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother 2000, 44(2):362-367.
23. Rossi F. The challenges of antimicrobial resistance in Brazil. Clin Infect Dis 2011, 52(9):1138-1143. 10.1093/cid/cir120.
24. Sennati S., Santella G., Di Conza J., Pallecchi L., Pino M., Ghiglione B., et al. Changing epidemiology of extended-spectrum beta-lactamases in Argentina: emergence of CTX-M-15. Antimicrob Agents Chemother 2012, 56(11):6003-6005. 10.1128/AAC.00745-12.
25. Tsai Y.-K., Liou C.-H., Fung C.-P., Lin J.-C., Siu L.K. Single or in combination antimicrobial resistance mechanisms of Klebsiella pneumoniae contribute to varied susceptibility to different carbapenems. PLoS One 2013, 8(11):e79640. 10.1371/journal.pone.0079640.